BIO — Bio-Rad Laboratories, Inc.
Is BIO overbought or oversold? Here is the current MarketMoodz read.
Bio-Rad Laboratories, Inc. (BIO) currently reads Neutral on the MarketMoodz overbought/oversold meter, as of July 5, 2026. The Healthcare name (Medical Devices) last closed at $296.86. The rating moved from Overbought to Neutral on July 3, 2026 and has changed 11 times in the last 90 days.
- Public ratingNeutral (as of July 5, 2026)
- Last close$296.86
- Rating changesRating changed 11 times in the last 90 days
- Last changeMoved from Overbought to Neutral on July 3, 2026
- SectorHealthcare
- IndustryMedical Devices
Latest MarketMoodz coverage
See today's live rating, score and targets
Members see the live hourly rating for BIO — the numeric AI score plus targets and entry zones — while this public page updates nightly.
Start the 14-day trialThis page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.
MarketMoodz